The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Open accessAbstract
The strategies involved in the development of therapeutics for neurodegenerative disorders are very complex and challenging due to the existence of the blood-brain barrier (BBB), a closely spaced network of blood vessels and endothelial cells that functions to prevent the entry of unwanted substances in the brain. The emergence and advancement of nanotechnology shows favourable prospects to overcome this phenomenon. Engineered nanoparticles conjugated with drug moieties and imaging agents that have dimensions between 1 and 100 nm could potentially be used to ensure enhanced efficacy, cellular uptake, specific transport, and delivery of specific molecules to the brain, owing to their modified physico-chemical features. The conjugates of nanoparticles and medicinal plants, or their components known as nano phytomedicine, have been gaining significance lately in the development of novel neuro-therapeutics owing to their natural abundance, promising targeted delivery to the brain, and lesser potential to show adverse effects. In the present review, the promising application, and recent trends of combined nanotechnology and phytomedicine for the treatment of neurological disorders (ND) as compared to conventional therapies, have been addressed. Nanotechnology-based efforts performed in bioinformatics for early diagnosis as well as futuristic precision medicine in ND have also been discussed in the context of computational approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, D., Ma, X.-L., Gu, Y., Huang, H., & Zhang, G.-W. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00799 · Cited by 436
RetractedNano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.03.001 · Cited by 4,265
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., & Moher, D. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.02.003 · Cited by 3,490
Epidemiology of Parkinson’s disease
Tysnes, O.-B., & Storstein, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1686-y · Cited by 2,414
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Non-ionic surfactant based vesicles (niosomes) in drug delivery
Uchegbu, I. F., & Vyas, S. P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00169-0 · Cited by 1,020
Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)
Shang, A., Cao, S.-Y., Xu, X.-Y., Gan, R.-Y., Tang, G.-Y., Corke, H., Mavumengwana, V., & Li, H.-B. (2019) · Foods · doi:10.3390/foods8070246 · Cited by 896
Treatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., & Schubert, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00134-0 · Cited by 757
Clinical trials of new drugs for Alzheimer disease
Huang, L.-K., Chao, S.-P., & Hu, C.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0609-7 · Cited by 702 · cited 1×
“In drug development, there are more than a hundred pipeline drugs under clinical investigation [130,131].”
BackgroundMechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications
Powell, C. R., Dillon, K. M., & Matson, J. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.11.014 · Cited by 599
McDannold, N., Arvanitis, C. D., Vykhodtseva, N., & Livingstone, M. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0128 · Cited by 588
Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review
Nieto, G., Ros, G., & Castillo, J. (2018) · Medicines · doi:10.3390/medicines5030098 · Cited by 574
Biopolymer based nanomaterials in drug delivery systems: A review
Jacob, J., Haponiuk, J. T., Thomas, S., & Gopi, S. (2018) · Materials Today Chemistry · doi:10.1016/j.mtchem.2018.05.002 · Cited by 573
Alzheimer’s disease drug development pipeline: 2020
Cummings, J., Lee, G., Ritter, A., Sabbagh, M., & Zhong, K. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12050 · Cited by 557
Ligand-targeted liposome design: challenges and fundamental considerations
Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 542
Alzheimer’s disease drug development pipeline: 2021
Cummings, J., Lee, G., Zhong, K., Fonseca, J., & Taghva, K. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12179 · Cited by 539
CSF, blood-brain barrier, and brain drug delivery
Pardridge, W. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1171315 · Cited by 508
Niwa, T., Takeuchi, H., Hino, T., Kunou, N., & Kawashima, Y. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90097-o · Cited by 483
HIV dementia: an evolving disease
McArthur, J. C. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.042 · Cited by 462
Mathew, A., Fukuda, T., Nagaoka, Y., Hasumura, T., Morimoto, H., Yoshida, Y., Maekawa, T., Venugopal, K., & Kumar, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032616 · Cited by 442
Yang, S., & Chang, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133130 · Cited by 408
Murakami, H., Kobayashi, M., Takeuchi, H., & Kawashima, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00187-8 · Cited by 405 · cited 1×
“Due to the use of solely miscible solvents, the modified spontaneous emulsification solvent technique is obviously a method of solvent displacement [44].”
MethodAdvances in the treatment of Parkinson's disease
Singh, N., Pillay, V., & Choonara, Y. E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.009 · Cited by 394
Silk-based delivery systems of bioactive molecules
Numata, K., & Kaplan, D. L. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.009 · Cited by 385
Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence
Hajialyani, M., Hosein Farzaei, M., Echeverría, J., Nabavi, S. M., Uriarte, E., & Sobarzo-Sánchez, E. (2019) · Molecules · doi:10.3390/molecules24030648 · Cited by 385
Neuroscience nanotechnology: progress, opportunities and challenges
Silva, G. A. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1827 · Cited by 382
Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer’s Disease
Reddy, P. H., Manczak, M., Yin, X., Grady, M. C., Mitchell, A., Tonk, S., Kuruva, C. S., Bhatti, J. S., Kandimalla, R., Vijayan, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170512 · Cited by 354
Protein-based nanoparticles: From preparation to encapsulation of active molecules
Tarhini, M., Greige-Gerges, H., & Elaissari, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.067 · Cited by 354
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Hussain, G., Rasul, A., Anwar, H., Aziz, N., Razzaq, A., Wei, W., Ali, M., Li, J., & Li, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.23247 · Cited by 351
Cano, A., Ettcheto, M., Chang, J.-H., Barroso, E., Espina, M., Kühne, B. A., Barenys, M., Auladell, C., Folch, J., Souto, E. B., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.010 · Cited by 337
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance
Bar-Zeev, M., Livney, Y. D., & Assaraf, Y. G. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.05.002 · Cited by 314
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders
Kabanov, A. V., & Gendelman, H. E. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.014 · Cited by 277
Mora-Huertas, C. E., Fessi, H., & Elaissari, A. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2011.02.005 · Cited by 274
Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263
A simple improved desolvation method for the rapid preparation of albumin nanoparticles
Jahanban-Esfahlan, A., Dastmalchi, S., & Davaran, S. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.05.032 · Cited by 254
Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets
Chopra, H., Dey, P. S., Das, D., Bhattacharya, T., Shah, M., Mubin, S., Maishu, S. P., Akter, R., Rahman, M. H., Karthika, C., et al. (2021) · Molecules · doi:10.3390/molecules26164998 · Cited by 238
Self-citationExosomes and Nanoengineering: A Match Made for Precision Therapeutics
Tran, P. H. L., Xiang, D., Tran, T. T. D., Yin, W., Zhang, Y., Kong, L., Chen, K., Sun, M., Li, Y., Hou, Y., et al. (2020) · Advanced Materials · doi:10.1002/adma.201904040 · Cited by 236
A molecular approach in drug development for Alzheimer’s disease
Agatonovic-Kustrin, S., Kettle, C., & Morton, D. W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.147 · Cited by 233
Magnetic targeting of nanoparticles across the intact blood–brain barrier
Kong, S. D., Lee, J., Ramachandran, S., Eliceiri, B. P., Shubayev, V. I., Lal, R., & Jin, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.021 · Cited by 226
Nanoparticle transport across the blood brain barrier
Grabrucker, A. M., Ruozi, B., Belletti, D., Pederzoli, F., Forni, F., Vandelli, M. A., & Tosi, G. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1153568 · Cited by 217 · cited 1×
“Therefore, the development of target-specific nano-drug delivery, which can pass through the BBB, can play an important role in the management and treatment of dementia or Alzheimer’s diseases [134,135].”
BackgroundSalvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects
Lopresti, A. L. (2017) · Drugs in R&D · doi:10.1007/s40268-016-0157-5 · Cited by 209
PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
McCall, R. L., & Sirianni, R. W. (2013) · Journal of Visualized Experiments · doi:10.3791/51015 · Cited by 208
Huang, W., & Zhang, C. (2018) · Biotechnology Journal · doi:10.1002/biot.201700203 · Cited by 204
Wang, Z., Yang, H., Wu, Z., Wang, T., Li, W., Tang, Y., & Liu, G. (2018) · ChemMedChem · doi:10.1002/cmdc.201800533 · Cited by 203
Waschbisch, A., Atiya, M., Linker, R. A., Potapov, S., Schwab, S., & Derfuss, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024604 · Cited by 195
LightBBB: computational prediction model of blood–brain-barrier penetration based on LightGBM
Shaker, B., Yu, M.-S., Song, J. S., Ahn, S., Ryu, J. Y., Oh, K.-S., & Na, D. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa918 · Cited by 192
Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease
Pinheiro, R. G. R., Granja, A., Loureiro, J. A., Pereira, M. C., Pinheiro, M., Neves, A. R., & Reis, S. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105314 · Cited by 190
Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies
Smith, M. W., & Gumbleton, M. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600650086 · Cited by 185
Treatment results: Parkinson's disease
Pollak, P., Fraix, V., Krack, P., Moro, E., Mendes, A., Chabardes, S., Koudsie, A., & Benabid, A.-L. (2002) · Movement Disorders · doi:10.1002/mds.10146 · Cited by 182
Khalil, A. T., Ovais, M., Ullah, I., Ali, M., Shinwari, Z. K., Khamlich, S., & Maaza, M. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0124 · Cited by 175
Suganthy, N., Sri Ramkumar, V., Pugazhendhi, A., Benelli, G., & Archunan, G. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-9789-4 · Cited by 174
Drug Delivery Across The Blood–Brain Barrier: Recent Advances in The Use of Nanocarriers
Mulvihill, J. J., Cunnane, E. M., Ross, A. M., Duskey, J. T., Tosi, G., & Grabrucker, A. M. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0367 · Cited by 173
Nanotechnological applications for the treatment of neurodegenerative disorders
Modi, G., Pillay, V., Choonara, Y. E., Ndesendo, V. M. K., du Toit, L. C., & Naidoo, D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.05.002 · Cited by 172
Yusuf, M., Khan, M., Khan, R. A., & Ahmed, B. (2013) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.747529 · Cited by 171
Phage‐Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine
Sunderland, K. S., Yang, M., & Mao, C. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201606181 · Cited by 171
Huntington’s Disease—Update on Treatments
Wyant, K. J., Ridder, A. J., & Dayalu, P. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0739-9 · Cited by 171
Functional role of ginseng-derived compounds in cancer
Ahuja, A., Kim, J. H., Kim, J.-H., Yi, Y.-S., & Cho, J. Y. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2017.04.009 · Cited by 168
Neuroprotective Role of Phytochemicals
Velmurugan, B. K., Rathinasamy, B., Lohanathan, B. P., Thiyagarajan, V., & Weng, C.-F. (2018) · Molecules · doi:10.3390/molecules23102485 · Cited by 163
Ultrasound-mediated drug delivery to the brain: principles, progress and prospects
Dasgupta, A., Liu, M., Ojha, T., Storm, G., Kiessling, F. M., & Lammers, T. (2016) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2016.07.007 · Cited by 162
Nischwitz, V., Berthele, A., & Michalke, B. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.08.018 · Cited by 159
RajaSankar, S., Manivasagam, T., Sankar, V., Prakash, S., Muthusamy, R., Krishnamurti, A., & Surendran, S. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.08.003 · Cited by 158
Dietary folate, vitamin B 12 , and vitamin B 6 and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (2006) · Neurology · doi:10.1212/01.wnl.0000225050.57553.6d · Cited by 157
Yang, X., Wu, J., & Sun, J. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.08.009 · Cited by 153
Biomolecular engineering for nanobio/bionanotechnology
Nagamune, T. (2017) · Nano Convergence · doi:10.1186/s40580-017-0103-4 · Cited by 150
Ovais, M., Zia, N., Ahmad, I., Khalil, A. T., Raza, A., Ayaz, M., Sadiq, A., Ullah, F., & Shinwari, Z. K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00284 · Cited by 150
Current and emerging avenues for Alzheimer's disease drug targets
Loera‐Valencia, R., Cedazo-Mínguez, Á., Kenigsberg, P.-A., Page, G., Duarte, A. I., Giusti, P., Zusso, M., Robert, P. H., Frisoni, G. B., Cattaneo, A., et al. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12959 · Cited by 150
Effects of Ginkgo biloba on dementia: an overview of systematic reviews
Yuan, Q., Wang, C.-W., Shi, J., & Lin, Z.-X. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.005 · Cited by 148
Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
Olasehinde, T. A., Olaniran, A. O., & Okoh, A. I. (2017) · Molecules · doi:10.3390/molecules22030480 · Cited by 148
A systematic review of minor phytocannabinoids with promising neuroprotective potential
Stone, N. L., Murphy, A. J., England, T. J., & O’Sullivan, S. E. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15185 · Cited by 141
RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer’s Disease
Pinheiro, R. G. R., Granja, A., Loureiro, J. A., Pereira, M. D. C., Pinheiro, M., Neves, A. R., & Reis, S. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02865-1 · Cited by 140
Exploring Pharmacological Mechanisms of Essential Oils on the Central Nervous System
Soares, G. A. B. E., Bhattacharya, T., Chakrabarti, T., Tagde, P., & Cavalu, S. D. (2021) · Plants · doi:10.3390/plants11010021 · Cited by 140
Self-citationXu, J., Wold, E. A., Ding, Y., Shen, Q., & Zhou, J. (2018) · Molecules · doi:10.3390/molecules23020474 · Cited by 131
Natural antidotes and management of metal toxicity
Amadi, C. N., Offor, S. J., Frazzoli, C., & Orisakwe, O. E. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05104-2 · Cited by 130
Phytochemistry and Pharmacology of Tinospora cordifolia: A Review
Tiwari, P. K., Nayak, P., Prusty, S. K., & Sahu, P. K. (2018) · Systematic Reviews in Pharmacy · doi:10.5530/srp.2018.1.14 · Cited by 129
Emmanuel, R., Saravanan, M., Ovais, M., Padmavathy, S., Shinwari, Z. K., & Periakaruppan, P. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.055 · Cited by 126
Overexpression of blood microRNAs 103a, 30b, and 29a in l -dopa–treated patients with PD
Serafin, A., Foco, L., Zanigni, S., Blankenburg, H., Picard, A., Zanon, A., Giannini, G., Pichler, I., Facheris, M., Cortelli, P., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001258 · Cited by 125
Nanocapsules for Drug Delivery: An Updated Review of the Last Decade
Erdoğar, N., Akkın, S., & Bilensoy, E. (2019) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/1872211313666190123153711 · Cited by 125
Precision Nanomedicine in Neurodegenerative Diseases
Goldsmith, M., Abramovitz, L., & Peer, D. (2014) · ACS Nano · doi:10.1021/nn501292z · Cited by 124
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
Caggiu, E., Paulus, K. S., Mameli, G., Arru, G., Sechi, G., & Sechi, L. A. (2018) · eNeurologicalSci · doi:10.1016/j.ensci.2018.09.002 · Cited by 124
Altered microRNA expression in B lymphocytes in multiple sclerosis
Sievers, C., Meira, M., Hoffmann, F., da Fontoura, P. P., Kappos, L., & Lindberg, R. L. P. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.04.002 · Cited by 121
Development of a novel niosomal system for oral delivery of Ginkgo biloba extract
Jin, Y., Wen, J., Garg, S., Zhang, L., Teng, L. R., Liu, & Zhou, Z. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s37984 · Cited by 118
Huang, W., Li, Z., Zhao, L., & Zhao, W. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.060 · Cited by 115
Evaluation of antioxidant activity of Ginkgo biloba phytosomes in rat brain
Suresh Ramnath, N. A. I. K., Pilgaonkar, V. W., & Panda, V. S. (2006) · Phytotherapy Research · doi:10.1002/ptr.1976 · Cited by 113
Zhao, Y., Xiong, S., Liu, P., Liu, W., Wang, Q., Liu, Y., Tan, H., Chen, X., Shi, X., Wang, Q., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272831 · Cited by 110
Giacomeli, R., Izoton, J. C., dos Santos, R. B., Boeira, S. P., Jessé, C. R., & Haas, S. E. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146325 · Cited by 109
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
Bergman, P., Piket, E., Khademi, M., James, T., Brundin, L., Olsson, T. P., Piehl, F., & Jagodic, M. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000219 · Cited by 108
The Treatment Strategies for Neurodegenerative Diseases by Integrative Medicine
Chen, X., & Pan, W. (2015) · Integrative Medicine International · doi:10.1159/000381546 · Cited by 101
Quintanar‐Guerrero, D., Allémann, É., Fessi, H., et al. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00216-1 · Cited by 98
Nanotechnologies for biomedical science and translational medicine
Heath, J. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515202112 · Cited by 98
Kishima, H., Poyot, T., Bloch, J., Dauguet, J., Condé, F., Dollé, F., Hinnen, F., Pralong, W. F., Palfi, S., Déglon, N., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.012 · Cited by 95
Ligand Exchange on Gold Nanorods: Going Back to the Future
Indrasekara, A. S. D. S., Wadams, R. C., & Fabris, L. (2014) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201400006 · Cited by 94
Lee, D. Y., Kim, H. W., Yang, H., et al. (2017) · Phytochemistry · doi:10.1016/j.phytochem.2017.02.006 · Cited by 94
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases
Popović, N., & Brundin, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.040 · Cited by 91
Xu, R., Wang, J., Xu, J., Song, X., Huang, H., Feng, Y., & Fu, C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s236922 · Cited by 91
Ingwersen, J., Menge, T., Wingerath, B., Kaya, D., Graf, J., Prozorovski, T., Keller, A., Backes, C., Beier, M., Scheffler, M., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.152 · Cited by 82
Soliman, H. M., Ghonaim, G. A., Gharib, S. M., Chopra, H., Farag, A. K., Hassanin, M. H., Nagah, A., Emad-Eldin, M., Hashem, N. E., Yahya, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910794 · Cited by 81
Self-citationAshraf, A., Zafar, S., Zahid, K., Shah, M. S., Al‐Ghanim, K. A., Al-Misned, F. A., & Mahboob, S. (2018) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2018.11.002 · Cited by 81
Remote modulation of neural activities via near-infrared triggered release of biomolecules
Li, W., Luo, R., Lin, X., Jadhav, A., Zhang, Z., Yan, L., Chan, C.-Y., Chen, X., He, J., Chen, C., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.06.041 · Cited by 80
Epidemiology of neuroimmunological diseases
Flachenecker, P. (2006) · Journal of Neurology · doi:10.1007/s00415-006-5001-3 · Cited by 79
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
Michell‐Robinson, M. A., Moore, C. S., Healy, L. M., Osso, L. A., Garbajs, N. Z., Grouza, V., Touil, H., Poliquin‐Lasnier, L., Trudelle, A., Giacomini, P. S., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.270 · Cited by 77
Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment
Ebrahimkhani, S., Beadnall, H. N., Wang, C., Suter, C. M., Barnett, M. H., Buckland, M. E., & Vafaee, F. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01792-6 · Cited by 77
Rahman, M., Akhter, S., Ahmad, M. Z., Ahmad, J., Addo, R. T., Ahmad, F. J., & Pichon, C. (2015) · Nanomedicine · doi:10.2217/nnm.15.68 · Cited by 76
Self-citationNanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases
Kumar, A., Chaudhary, R. K., Singh, R., SINGH, S. P., Wang, S., Hoe, Z.-Y., Pan, C., Shiue, Y., Wei, D., Kaushik, A. C., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00305 · Cited by 76
Xue, Y., Wang, N., Zeng, Z., Huang, J., Xiang, Z., & Guan, Y. (2019) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2019.10.013 · Cited by 75
Yusuf, M., Khan, M., Alrobaian, M. M., Alghamdi, S. A., Warsi, M. H., Sultana, S., & Khan, R. A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102214 · Cited by 72
Antonescu, A.-I. M., Miere, F. G., Fritea, L., Ganea, M., Zdrîncă, M. M., Dobjanschi, L., Antonescu, A., Vicaş, S. I., Bodog, F., Sindhu, R. K., et al. (2021) · Plants · doi:10.3390/plants10071390 · Cited by 71
Self-citationmiRNA expression is highly sensitive to a drug therapy in Parkinson's disease
Alieva, A. K., Filatova, E. V., Karabanov, A. V., Illarioshkin, S. N., Limborska, S. A., Shadrina, M. I., & Slominsky, P. A. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.10.018 · Cited by 69
Cheng, Z., Zhang, J., Liu, H., Li, Y., Zhao, Y., & Yang, E. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033324 · Cited by 68
Nanotheranostics of Circulating Tumor Cells, Infections and Other Pathological Features in Vivo
Kim, J.-W., Galanzha, E. I., Zaharoff, D. A., Griffin, R. J., & Zharov, V. P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300577s · Cited by 64
Drug delivery into the brain using poly(lactide-co-glycolide) microspheres
Meneï, P., Montero‐Menei, C. N., Venier‐Julienne, M., & Benoît, J. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.363 · Cited by 64
Vascular disorder in Alzheimer’s disease: role in pathogenesis of dementia and therapeutic targets
Zloković, B. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00150-3 · Cited by 63
Late‐onset neurodegenerative diseases—the role of protein insolubility
Johnson, W. G. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640609.x · Cited by 62
Biosynthesized Colloidal Silver and Gold Nanoparticles As Emerging Leishmanicidal Agents: an Insight
Ovais, M., Nadhman, A., Khalil, A. T., Raza, A., Khuda, F., Sohail, M. F., Ullah, N., Islam, N. U., Sarwar, H. S., Shahnaz, G., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0233 · Cited by 62
Li, J., Han, Y., Li, M., & Nie, C. (2019) · Cellular Reprogramming · doi:10.1089/cell.2018.0027 · Cited by 62
A Systematic Review of Single Chinese Herbs for Alzheimer′s Disease Treatment
Fu, L., & Li, J.-T. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep136 · Cited by 58
Shi, R., Zhang, S., Cheng, G., Yang, X., Zhao, N., & Chen, C. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2567-y · Cited by 58
Joshi, S., Singh‐Moon, R. P., Ellis, J. A., Chaudhuri, D. B., Wang, M., Reif, R., Bruce, J. N., Bigio, I. J., & Straubinger, R. M. (2014) · Neurosurgery · doi:10.1227/neu.0000000000000552 · Cited by 57
Muñoz‐Culla, M., Irizar, H., Castillo‐Triviño, T., Sáenz-Cuesta, M., Sepúlveda, L., Lopetegi, I., de Munaín, A. L., Olascoaga, J., Baranzini, S. E., & Otaegui, D. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514534513 · Cited by 57
Banks, W. A., & Greig, N. H. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0436 · Cited by 55
Singh, J., Deshpande, M., Suhail, H., Rattan, R., & Giri, S. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9630-0 · Cited by 53
Sancini, G. (2013) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000171 · Cited by 53
Strategies and Therapies for Wound Healing: A Review
Chopra, H., Kumar, S., & Singh, I. (2021) · Current Drug Targets · doi:10.2174/1389450122666210415101218 · Cited by 53
Self-citationBensadoun, J., de Almeida, L. P., Fine, E. G., Tseng, J., Déglon, N., & Aebischer, P. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00353-x · Cited by 52
Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson’s Disease
Schwienbacher, C., Foco, L., Picard, A., Corradi, E., Serafin, A., Panzer, J., Zanigni, S., Blankenburg, H., Facheris, M., Giannini, G., et al. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0926-9 · Cited by 52
The Anti-dementia Effects of Donepezil Involve miR-206-3p in the Hippocampus and Cortex
Wang, C., Wang, Y., Wang, H., Song, L., Chen, Y., Wang, J., Ye, Y., & Jiang, B. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00898 · Cited by 51
Small non-coding RNA signature in multiple sclerosis patients after treatment with interferon-β
Felice, B. D., Mondola, P., Sasso, A., Orefice, G., Morra, V. B., Vacca, G., Biffali, E., Borra, M., & Pannone, R. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-26 · Cited by 50
Cavalu, S. D., Antoniac, I., Mohan, A. G., Bodog, F. D., Doicin, C. V., Mateș, I. M., Ulmeanu, M., Murzac, R., & Semenescu, A. (2020) · Materials · doi:10.3390/ma13235391 · Cited by 50
Self-citationMonocyte Chemotactic Protein-1 Regulates Voltage-Gated K+ Channels and Macrophage Transmigration
Gendelman, H. E., Ding, S., Gong, N., Liu, J., Ramirez, S. H., Persidsky, Y., Mosley, R. L., Wang, T., Volsky, D. J., & Xiong, H. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9135-1 · Cited by 49
Sathya, S., Shanmuganathan, B., & Devi, K. P. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110948 · Cited by 48
Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47
Self-citationBiomedical Nanotechnology Related Grand Challenges and Perspectives
Kaushik, A. K. (2019) · Frontiers in Nanotechnology · doi:10.3389/fnano.2019.00001 · Cited by 47
Cavalu, S. D., Prokisch, J., Laslo, V., & Vicaş, S. I. (2016) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2016.0107 · Cited by 46
Self-citationLi, S.-H., Gao, P., Wang, L.-T., Yan, Y.-H., Xia, Y., Song, J., Li, H.-Y., & Yang, J.-X. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00340 · Cited by 46
Global Data Sharing in Alzheimer Disease Research
Ashish, N., Bhatt, P. R., & Toga, A. W. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000121 · Cited by 41
Cavalu, S. D., Bisboaca, S., Mateș, I. M., Pasca, P. M., Laslo, V., Costea, T. O., Fritea, L., & Vicaş, S. I. (2019) · Revista de Chimie · doi:10.37358/rc.18.12.6836 · Cited by 41
Self-citationMiR-126: a novel route for natalizumab action?
Meira, M., Sievers, C., Hoffmann, F., Derfuss, T. J., Kühle, J., Kappos, L., & Lindberg, R. L. P. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514524998 · Cited by 40
Fenoglio, C., Riz, M. A. D., Pietroboni, A. M., Calvi, A., Serpente, M., Cioffi, S., Arcaro, M., Oldoni, E., Scarpini, E. A., & Galimberti, D. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.017 · Cited by 39
Biopolymer-based Scaffolds for Tissue Engineering Applications
Chopra, H., Kumar, S., & Singh, I. (2020) · Current Drug Targets · doi:10.2174/1389450121999201102140408 · Cited by 38
Self-citationTan, J. P. K., Voo, Z. X., Lim, S. W. Z., Venkataraman, S., Ng, K. M., Gao, S., Hedrick, J. L., & Yang, Y. Y. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.014 · Cited by 37
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
Vaknin‐Dembinsky, A., Charbit, H., Brill, L., Abramsky, O., Gur‐Wahnon, D., Ben‐Dov, I. Z., & Lavon, I. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0648-x · Cited by 35
Belmadani, M., Jacobson, M., Holmes, N., Phan, M., Nguyen, T. G., Pavlidis, P., & Rogić, S. (2019) · Autism Research · doi:10.1002/aur.2236 · Cited by 33
HERBAL MEDICINES AS NEUROPROTECTIVE AGENT: A MECHANISTIC APPROACH
Roy, S., & Awasthi, H. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i11.19444 · Cited by 32
Kaushik, A. C., Kumar, A., Peng, Z., Khan, A., Junaid, M., Ali, A., Bharadwaj, S., & Wei, D.-Q. (2019) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/jmr.2018.452 · Cited by 32
Family history of dementia is a risk factor for Lewy body disease
Woodruff, B. K., Graff‐Radford, N. R., Ferman, T. J., Dickson, D. W., DeLucia, M. W., Crook, J. E., Arvanitakis, Z., Brassler, S., Waters, C., Barker, W., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000219812.20616.b3 · Cited by 31
Nanomedicine for Acute Brain Injuries: Insight from Decades of Cancer Nanomedicine
Kandell, R. M., Waggoner, L. E., & Kwon, E. J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00287 · Cited by 27
Nanoinformatics: developing new computing applications for nanomedicine
Maojo, V., Fritts, M. J., Martin-Sanchez, F. J., de la Iglesia, D., Cachau, R. E., García-Remesal, M., Crespo, J., Mitchell, J. A., Anguita, A., Baker, N., et al. (2012) · Computing · doi:10.1007/s00607-012-0191-2 · Cited by 26
Eftekharian, M. M., Komaki, A., Mazdeh, M., et al. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01294-z · Cited by 25
Chowdhury, S. R., Mondal, S., Balakrishnan, M., Balaji, S., Trivedi, V., & Iyer, P. K. (2018) · ACS Omega · doi:10.1021/acsomega.8b00764 · Cited by 23
Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview
Abdolmaleki, A., Akram, M., Saeed, M. M., et al. (2020) · Journal of Pharmaceutical Care · doi:10.18502/jpc.v8i2.3832 · Cited by 22
Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease
Dickson, D. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci17164 · Cited by 19
Kusindarta, D. L., Wihadmadyatami, H., Jadi, A. R., Karnati, S., Lochnit, G., Hening, P., Haryanto, A. T., Mataram, M. B. A., & Purwaningrum, M. (2018) · Research in Veterinary Science · doi:10.1016/j.rvsc.2018.04.005 · Cited by 19
Fattahi, M., Rezaei, N., Nematalahi, F. S., Shaygannejad, V., Fouladi, S., Karimi, L., Fathi, F., Dehghani, L., Mirmosayyeb, O., & Eskandari, N. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.07.034 · Cited by 19
Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease
Dickson, D. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0217164 · Cited by 14
Jang, M., Choi, S.-H., Choi, J. H., Oh, J., Lee, R., Lee, N.-E., Cho, Y., Rhim, H., Kim, H., Cho, I., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9741 · Cited by 13
Poka, L. P., Krishna Mohan, G., Venkateswara Rao, K., & Shanker, K. (2017) · International Journal of Pharmacognosy and Phytochemical Research · doi:10.25258/phyto.v9i5.8152 · Cited by 11
Inorganic nanotheranostics: Strategy development and applications
Tripathy, N., Ahmad, R., & Khang, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50922-0.00017-1 · Cited by 11
Fattahi, M., Eskandari, N., Sotoodehnejadnematalahi, F., Shaygannejad, V., & Kazemi, M. (2020) · PubMed Central · doi:10.22074/cellj.2020.6486 · Cited by 11
Owoeye, O., Obazie, F. I. I., Atiba, F. A., & Malomo, A. O. (2019) · Nigerian Journal of Physiological Sciences · Cited by 10
João, E. F., Dâmaris, S., Aluízio, C. S., Fabiana, P. C., Melissa, S. D. A., Franco, B. L., Niraldo, P., Greice, M. S., Mônica, V. D. S., Marchiori, S., et al. (2017) · Journal of Medicinal Plants Research · doi:10.5897/jmpr2016.6266 · Cited by 9
Special issue on neurodegenerative diseases and their therapeutic approaches
Kim, J., & Mook-Jung, I. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.13 · Cited by 8 · cited 1×
“Revelatory endeavours for sickness-changing therapeutics have lately significantly expanded, because of a more noteworthy comprehension of the pathogenesis of these infections [22].”
BackgroundA STUDY ON NOOTROPIC ACTIVITY OF CELASTRUS PANICULATA WILLD WHOLE PLANT METHANOLIC EXTRACT IN RATS
Jakka, A. L. (2016) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 5
Zloković, B. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00147-3 · Cited by 3
Cited by
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Green Metallic Nanoparticles: Biosynthesis to Applications
Chopra, H., Bibi, S., Singh, I., Hasan, M. M., Khan, M. S., Yousafi, Q., Baig, A. A., Rahman, M. M., Islam, F., Emran, T. B., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.874742 · Cited by 278
Self-citationBiofabrication of nanoparticles: sources, synthesis, and biomedical applications
Kulkarni, D., Sherkar, R., Shirsathe, C., Sonwane, R., Varpe, N., Shelke, S., More, M. P., Pardeshi, S. R., Dhaneshwar, G., Junnuthula, V., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1159193 · Cited by 267
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., -Or-Rashid, M. H., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 253
Self-citationSharma, R., Singla, R. K., Banerjee, S., Sinha, B., Shen, B., & Sharma, R. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104795 · Cited by 81
Metadata
- Authors
- Bhattacharya, T., Soares, G. A. B. E., Chopra, H., Rahman, M. M., Hasan, Z., Swain, S. S., & Cavalu, S.
- Venue
- Materials
- Publisher
- MDPI AG
- Published
- 2022-01-21
- Volume
- 15
- Issue
- 3
- Pages
- 804
- ISSN
- 1996-1944 (ISSN-L)
- OpenAlex
- W4206408372
- Cited by
- 259
- References
- 172
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.